Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease Evidence Review and Practical Considerations

被引:10
|
作者
Copeland, Carla R. [1 ]
Collins, Bridget F. [2 ]
Salisbury, Margaret L. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37235 USA
[2] Univ Washington, Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
environmental lung disease; hypersensitivity pneumonitis; pulmonary fibrosis; IDIOPATHIC PULMONARY-FIBROSIS; OCCUPATIONAL HYPERSENSITIVITY PNEUMONITIS; ASTHMA MORBIDITY; FARMERS LUNG; RISK-FACTORS; CIGARETTE-SMOKING; PROTECTIVE VALUE; MULTI-TRIGGER; ANTIGEN; METAL;
D O I
10.1016/j.chest.2021.02.021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A relationship between inhalational exposure to materials in the environment and development of interstitial lung disease (ILD) is long recognized. Hypersensitivity pneumonitis is an environmentally -induced diffuse parenchymal lung disease. In addition to hypersensitivity pneumonitis, domestic and occupational exposures have been shown to influence onset and progression of other ILDs, including idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis. A key component of the clinical evaluation of patients presenting with ILD includes elucidation of a complete exposure history, which may influence diagnostic classification of the ILD as well as its management. Currently, there is no standardized approach to environmental evaluation or remediation of potentially harmful exposures in home or workplace environments for patients with ILD. This review discusses evidence for environmental contributions to ILD pathogenesis and draws on asthma and occupational medicine literature to frame the potential utility of a professional evaluation for environmental factors contributing to the development and progression of ILD. Although several reports suggest benefits of environmental assessment for those with asthma or certain occupational exposures, lack of information about benefits in broader populations may limit application. Determining the feasibility, long-term outcomes, and cost-effectiveness of environmental evaluation and remediation in acute and chronic ILDs should be a focus of future research.
引用
收藏
页码:219 / 230
页数:12
相关论文
共 50 条
  • [31] Interstitial Lung Disease in Rheumatoid Arthritis: A Review
    Al-Baldawi, Shahad
    Salazar, Gabriel Zuniga
    Zuniga, Diego
    Balasubramanian, Sneha
    Mehmood, Khawar Tariq
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [32] Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis
    Kim, Dam
    Cho, Soo-Kyung
    Choi, Chan-Bum
    Choe, Jung-Yoon
    Chung, Won Tae
    Hong, Seung-Jae
    Jun, Jae-Bum
    Jung, Young Ok
    Kim, Tae-Hwan
    Kim, Tae-Jong
    Lee, Hye-Soon
    Lee, Joo-Hyun
    Lee, Jisoo
    Lee, Shin-Seok
    Yoo, Dae-Hyun
    Yoon, Bo Young
    Song, Jin Woo
    Bae, Sang-Cheol
    Sung, Yoon-Kyoung
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (10) : 1735 - 1745
  • [33] Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
    Matteson, Eric L.
    Bendstrup, Elisabeth
    Strek, Mary E.
    Dieude, Philippe
    ACR OPEN RHEUMATOLOGY, 2024, 6 (12) : 836 - 845
  • [34] Symptom prevalence of patients with fibrotic interstitial lung disease: a systematic literature review
    Sabrina Carvajalino
    Carla Reigada
    Miriam J. Johnson
    Mendwas Dzingina
    Sabrina Bajwah
    BMC Pulmonary Medicine, 18
  • [35] Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease
    Lee, Joyce S.
    Fischer, Aryeh
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (05) : 509 - 520
  • [36] Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
    d'Alessandro, Miriana
    Bergantini, Laura
    Cameli, Paolo
    Vietri, Lucia
    Lanzarone, Nicola
    Alonzi, Valerio
    Pieroni, Maria
    Refini, Rosa M.
    Sestini, Piersante
    Bonella, Francesco
    Bargagli, Elena
    BIOMARKERS IN MEDICINE, 2020, 14 (08) : 675 - 682
  • [37] Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis
    Paulin, Francisco
    Jennifer Doyle, Tracy
    Francisco Mercado, Juan
    Fassola, Leandro
    Fernandez, Martin
    Caro, Fabian
    Laura Alberti, Maria
    Crespo Espindola, Maria Elena
    Buschiazzo, Emilio
    REUMATOLOGIA CLINICA, 2021, 17 (04): : 207 - 211
  • [38] Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features
    Cooper, Wendy A.
    Mahar, Annabelle
    Myers, Jeffrey L.
    Grainge, Christopher
    Corte, Tamera J.
    Williamson, Jonathan P.
    Vallely, Michael P.
    Lai, Simon
    Mulyadi, Ellie
    Torzillo, Paul J.
    Phillips, Martin J.
    Lau, Edmund M. T.
    Raghu, Ganesh
    Troy, Lauren K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (10) : 1306 - 1313
  • [39] Fibrosing Interstitial Lung Disease A Practical High-Resolution Computed Tomography-based Approach to Diagnosis and Management and a Review of the Literature
    Hodnett, Philip A.
    Naidich, David P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (02) : 141 - 149
  • [40] Treating lung cancer in patients with interstitial lung disease: what do we know?
    Graur, Alexander
    Montesi, Sydney B.
    Lanuti, Michael
    Fintelmann, Florian J.
    JOURNAL OF THORACIC DISEASE, 2023, 15 (04) : 1555 - 1558